Gilles de la Tourette syndrome: Symptomatic treatment based on evidence

European Child and Adolescent Psychiatry

Volumn 9, Issue SUPPL. 1, 2000, Pages

  Robertson, M M ^a   Stern, J S ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Gilles de la Tourette syndrome; Management; Treatment; Trials

Indexed keywords

ANTIDEPRESSANT AGENT; BOTULINUM TOXIN A; CALCIUM ANTAGONIST; CENTRAL STIMULANT AGENT; CLONIDINE; FLUVOXAMINE; GUANFACINE; NICOTINE; PERGOLIDE; PIMOZIDE; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; TETRABENAZINE; TIAPRIDE;

ARTICLE; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL SYMPTOM; GILLES DE LA TOURETTE SYNDROME; HEADACHE; HORMONAL REGULATION; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; INVOLUNTARY MOVEMENT; NAUSEA; PREVALENCE; RESTLESSNESS; TIC; VOMITING;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BEHAVIOR THERAPY; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DEMOGRAPHY; DOPAMINE ANTAGONISTS; FEMALE; HORMONES; HUMANS; IMMUNOTHERAPY; MALE; PIMOZIDE; PREVALENCE; SEROTONIN UPTAKE INHIBITORS; SULPIRIDE; TOURETTE SYNDROME;

EID: 0033667056     PISSN: 10188827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007870070020     Document Type: Article

References (190)

1. Follow-up study of children of childhood tiquers
2. School problems in Tourette's syndrome
3. Possible interaction between fluoxetine and pimozide causing sinus bradycardia
4. Nifedipine-haloperidol combination in the treatment of Gilles de la Tourette's syndrome: A case study
5. An epidemiological study of Gilles de la Tourette's syndrome in Israel
6. Habit reversal for the treatment of Tourette syndrome
7. Genetic analysis of Tourette syndrome suggesting major gene effect
8. A case of Tourette syndrome treated with nifedipine
9. Relaxation therapy in Tourette syndrome: A pilot study
10. Limitations of the application of fourfold table analysis to hospital data
11. Olanzepine in Tourette syndrome
12. Tourette syndrome treated with nifedipine
13. Treatment approaches in Gilles de la Tourette syndrome
14. Fluoxetine and extrapyramidal side effects
15. Gilles de la Tourette's syndrome: An overview of clinical experience
16. Subtle and underrecognised side effects of neuroleptic treatment in children with Tourette's disorder
17. Risperidone as a treatment for Tourette's syndrome
18. Viral infection and tic exacerbation
19. Treatment-generated problems associated with behavior modification in Tourette disorder
20. The trial use of clozapine for abnormal involuntary movement disorders
21. The efficacy of several treatments of Gilles de la Tourette's syndrome as assessed in a single case
22. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose
23. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: Preliminary clinical experience
24. Behavioral approaches to treatment of Gilles de la Tourette's syndrome
25. Treatment of refractory Tourette syndrome with haloperidol decanoate
26. Clomipramine in the treatment of patients with obsessive-compulsive disorders
27. Clonidine ameliorates Gilles de la Tourette's syndrome
28. A controlled study of Tourette Syndrome: 1. Attention deficit disorder, learning disorders and school problems
29. An epidemiologic study of Tourette's syndrome in a single school district
30. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: The additive and subtractive effect of three dopaminergic genes - DRD2, DBetaH, DAT1
31. The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-R Disorders
32. Autosomal dominant gene transmission in a large kindred with Gilles de la Tourette syndrome
33. Clinical predictors of psychopathology in children and adolescents with Tourette Syndrome
34. Fluvoxamine/pimozide treatment of concurrent Tourette's and obsessive-compulsive disorder
35. A case with Gilles de la Tourette's syndrome: Recurrent refractoriness to haloperidol, and unsuccessful treatment with L-dopa
36. The use of imipramine in Tourette's syndrome and attention deficit disorder: Case report
37. Tourette's syndrome and treatment with Clomipramine hydrochloride
38. Therapeutic effects of clonazepam in children with tic syndrome
39. Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: An open study
40. Sulpiride induced tardive dyskinesia in a person with Gilles de la Tourette syndrome
41. Evidence for autosomal dominant transmission in Gilles de la Tourette syndrome - United Kingdom cohort
42. All that tics may not be Tourette's
43. The use of fluoxetine in Gilles de la Tourette syndrome and obsessive compulsive behaviours: Preliminary clinical experience
44. Gilles de la Tourette's syndrome in special education schools: A United Kingdom study
45. Obsessive compulsive symptoms in Gilles de la Tourette syndrome and obsessive compulsive disorder: Differences by diagnosis and family history
46. Sex of parent transmission effect in Tourette's syndrome: Evidence for earlier age at onset in maternally transmitted cases suggests a genomic imprinting effect
47. Clinical and neurobiological findings in children suffering from tic disease following treatment with tiapride
48. Tourette syndrome: An analysis of 200 pediatric and adolescent cases
49. Comparison of lithium and haloperidol therapy in Gilles de la Tourette syndrome
50. Methodology of epidemiological studies of tic disorders and comorbid psychopathology
51. A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder
52. Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder
53. Children with Tourette syndrome; results of psychological tests given prior to drug treatment
54. Obsessions and compulsions in Gilles de la Tourette's syndrome
55. ECG changes during haloperidol and pimozide treatment of Tourette's disorder
56. Methylphenidate in hyperactive boys with comorbid tic disorder: II Short-term behavioral effects in school settings
57. Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder
58. Treatment of Tourette's syndrome with transdermal clonidine: A pilot study
59. Fluvoxamine and sulpiride in comorbid obsessive-compulsive disorder and Gilles de la Tourette syndrome
60. Clonidine and Gilles de la Tourette's syndrome: Double-blind study using objective rating methods
61. Nifedipine treatment of Tourette's syndrome (letter)
62. Pergolide in the management of Tourette syndrome
63. Intermediate inheritance of Tourette syndrome, assuming assortive mating
64. Gilles de la Tourette's syndrome (maladie des tics). Successful treatment with haloperidol
65. Progress in gene localization
66. A case of Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine
67. Unsuccessful use of massed practice in the treatment of Gilles de la Tourette's syndrome
68. Risperidone in the treatment of affective illness and obsessive compulsive disorder
69. Botulinum toxin in the treatment of dystonic tics
70. Long-term effects of tetrabenazine in hyperkinetic movement disorders
71. Genetic hypotheses for Tourette Syndrome
72. Antineuronal antibodies in movement disorders
73. A controlled trial of propoxyphene and naltrexone in patients with Tourette's syndrome
74. A pilot controlled study of fluoxetine for obsessive-compulsive symptoms in children with Tourette's syndrome
75. Tourette's syndrome in a special education population: A pilot study involving a single school district
76. Bilineal transmission in Tourette syndrome families
77. Non-obscene complex socially inappropriate behavior in Tourette's syndrome
78. Behavior deviations in a representative sample of children
79. Short- and long-term treatment of Tourette's syndrome with clonidine: A clinical perspective
80. Nongenetic factors in Gilles de la Tourette's syndrome
81. The Yale Global Tic Severity Scale: Initial testing of a clinician rated scale of tic severity
82. Perinatal factors in the expression of Tourette's syndrome: An exploratory study
83. Clonidine treatment of Gilles de la Tourette's syndrome
84. Course of tic severity in Tourette syndrome: The first two decades
85. Tics and Tourette's Disorder: A 2-7 year follow-up of 54 obsessive-compulsive children
86. Fluoxetine-induced akathesia - Clinical and theoretical implications
87. Dopamine agonist treatment of Tourette disorder in children: Results of an open-label trial of pergolide
88. Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder
89. Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report
90. Cognitive-behavioral treatments for children and adolescents with OCD: A review and recommendations for treatment
91. The prevalence of Tourette syndrome in a mainstream school population
92. The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder
93. The efficacy of fluvoxamine in OCD: Effects of comorbid chronic tic disorder
94. Vocal tics in Sydenham's chorea (letter)
95. A pharmacotherapeutic rationale for the use of lithium carbonate in Tourette's syndrome
96. Methadone treatment of Tourette's disorder (letter)
97. Treatment of Tourette's syndrome with calcium antagonists
98. Stress management and Gilles de la Tourette's syndrome
99. The treatment of children with Gilles de la Tourette's syndrome
100. Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders
101. Exacerbation of tics following antidepressant therapy in a case of Gilles de la Tourette syndrome (letter)
102. Immunoglobulin therapy in Gilles de la Tourette syndrome
103. Gilles de la Tourette syndrome, influence of nicotine, alcohol and marijuana on the clinical symptoms
104. Cannabinoids: Possible role in patho-physiology and therapy of Gilles de la Tourette syndrome
105. Children with ADHD and tic disorder and their classmates: Behavioral normalization with methylphenidate
106. Social and educational resources for patients with Tourette syndrome
107. Progress in the search for genetic linkage with Tourette syndrome: An exclusion map covering more than 50 percent of the autosomal genome
108. Treatment of Gilles de la Tourette syndrome with depot neuroleptics
109. Gilles de la Tourette's Syndrome and attention deficit disorder with hyperactivity. Evidence against a genetic relationship
110. Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering
111. Empirically supported psychosocial treatments for attention deficit hyperactivity disorder
112. An evaluation of behavioral treatments for Tourette syndrome
113. Steroid hormones and Tourette's syndrome: Early experience with antiandrogen therapy
114. A double-blind placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome
115. Clinical features distinguishing patients with Tourette's syndrome and obsessive-compulsive disorder from patients with obsessive-compulsive disorder without tics
116. Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy
117. Clomipramine efficacy for tics, obsessions and compulsions in Tourette's syndrome and obsessive-compulsive disorder - A case-study
118. Neurosurgical treatment of Tourette's syndrome: A critical review
119. Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome
120. Seignot's paper on the treatment of Tourette's syndrome with haloperidol
121. Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: Preliminary clinical experience
122. The psychopathology of the Gilles de la Tourette syndrome: A phenomenological analysis
123. The Gilles de la Tourette syndrome: The current status
124. Self-injurious behaviour and the Gilles de la Tourette syndrome: A clinical study and review of the literature
125. Familial Tourette's syndrome in a large British pedigree: Associated psychopathology, severity and potential for linkage analysis
126. Management of Gilles de la Tourette syndrome using sulpiride
127. The pharmacologic controversy of CNS stimulants in Gilles de la Tourette syndrome
128. The psychopathology of Gilles de la Tourette syndrome: A controlled study
129. Annotation: Gilles de la Tourette syndrome - An update
130. The relationship between Gilles de la Tourette syndrome and obsessive compulsive disorder
131. Tourette syndrome, associated conditions and the complexities of treatment
132. Risperidone in the treatment of Tourette syndrome: A retrospective case note study
133. Personality disorder and psychopathology in Tourette's syndrome: A controlled study
134. Relationship of the child behavior checklist to an independent measure of psychopathology
135. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette syndrome
136. Pharmokinetics of pimozide in adults and children with Tourette's syndrome
137. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder
138. Bullying in schools: Self-reported anxiety, depression and self-esteem in secondary school children
139. Nicotine gum and haloperidol in Tourette's syndrome
140. Treatment of Tourette's syndrome with mecamylamine
141. Failure to establish Control over tics in the Gilles de la Tourette syndrome with behaviour therapy techniques
142. Tourette syndrome: A follow-up study
143. Tourette syndrome: Successful treatment with clonidine and oxycodone
144. Estrogen as adjuvant treatment of Tourette syndrome
145. Clomiphene citrate in Tourette syndrome
146. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: A double-blind placebo-controlled study
147. Botulinum toxin injections into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
148. Treating Tourette syndrome with haloperidol: Predictors of success
149. Novel use of tramadol hydrochloride in the treatment of Tourette's syndrome
150. Treatment of Gilles de la Tourette's syndrome with pimozide
151. Treatment of Gilles de la Tourette's syndrome with clonidine and neuroleptics
152. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome
153. Causes of haloperidol discontinuation in patients with Tourette's disorder: Management and alternatives
154. Serotoninergic agents in the treatment of Gilles de la Tourette's syndrome
155. Haloperidol, fluphenazine and clonidine in Tourette syndrome: Controversies in treatment
156. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: A double-blind placebo-controlled study with clonidine and desipramine
157. Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome
158. Nortriptyline treatment of children with attention-deficit hyperactivity disorder or Tourette's syndrome
159. Tricyclic antidepressant treatment of children with ADHD and tic disorders
160. Disentangling the overlap between Tourette's disorder and ADHD
161. Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders
162. Tics associated with autistic and pervasive developmental disorders
163. Massed negative practice as a behavioral treatment for Gilles de la Tourette's syndrome
164. Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette's syndrome
165. Case study: A new infection triggered autoimmune subtype of pediatric obsessive-compulsive disorder and Tourette syndrome
166. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases
167. Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine
168. Clinical guidelines for hyperkinetic disorder
169. Gilles de la Tourette's syndrome: A study of the treatment of six cases by mass negative practice and without haloperidol
170. A follow-up study of children with tics
171. Vocal tics in Gilles de la Tourette syndrome treated with Botulinum toxin injections
172. Case report of four patients with Tourette syndrome treated with piquindone, a D2 receptor antagonist
173. Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus
174. Mental health in Dutch children: A cross-cultural comparison
175. Periodic limb movements during sleep are a frequent finding in patients with Gilles de la Tourette syndrome
176. Family study and segregation analysis of Tourette syndrome: Evidence for a mixed model of inheritance
177. Calcium antagonists in the treatment of Tourette's disorder
178. Tourette syndrome and medical treatments in Canada
179. Tourette syndrome: Associated symptoms and most disabling features
180. Tourette's syndrome: A disorder of cingulate and orbitofrontal function
181. Behavior disturbance in children with Tourette Syndrome
182. Tourette's syndrome and psychopathology in a child psychiatry setting
183. 156 cases of Gilles de la Tourette syndrome treated by acupuncture
184. The treatment of tics in childhood; a review and follow-up study
185. Normative and pathological obsessive-compulsive behavior and ideation in childhood: A question of timing